Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Immunization Schedules of Beijing Tiantan Biological's MMR Vaccine in 18-72 Month-Old Children

NCT03160820 is registered in ClinicalTrials.gov with Centers for Disease Control and Prevention, China as lead sponsor.

NCT NCT03160820
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03160820 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Immunization Schedules of Beijing Tiantan Biological's MMR Vaccine in 18-72 Month-Old Children
Lead sponsor
Centers for Disease Control and Prevention, China
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2016
Completion date
February 28, 2017
Enrollment
873 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

adverse event following immunisation, measles, mumps, rubella